<DOC>
	<DOC>NCT00444106</DOC>
	<brief_summary>To evaluate the potential effects of artemether- lumefantrine on the auditory function</brief_summary>
	<brief_title>Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<mesh_term>Proguanil</mesh_term>
	<mesh_term>Atovaquone</mesh_term>
	<mesh_term>Atovaquone, proguanil drug combination</mesh_term>
	<criteria>Inclusion Criteria 12 years of age or older Accepts Healthy Volunteers P. falciparum parasitemia between 1,000 and 100,000 parasites/μl History of fever or presence of fever (temperature ≥ 37.5°C) Exclusion Criteria Signs/symptoms of severe/complicated malaria Ingestion of various antimalarial drugs, or antibiotics in the previous 2 weeks to 2 months History of any drugrelated hearing impairment Abnormal hearing function at study entry Exposure to sustained loud noises, by selfreport, within the past 24 hours Present ear problems Pregnant or lactating (urine test for βHCG) to be performed on any woman of child bearing age) Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Malaria</keyword>
	<keyword>hearing</keyword>
	<keyword>co-artemether</keyword>
	<keyword>auditory</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>marsh fever</keyword>
	<keyword>Plasmodium infections</keyword>
	<keyword>remittent fever</keyword>
	<keyword>paludism</keyword>
	<keyword>artemether</keyword>
	<keyword>artemisinins</keyword>
	<keyword>benflumetol</keyword>
	<keyword>lumefantrine</keyword>
</DOC>